Synthesis, Anti-Inflammatory, and Molecular Docking Studies of New Heterocyclic Derivatives Comprising Pyrazole, Pyridine, and/or Pyran Moieties
Pharmaceuticals · 26.02.2025 · 18 (3) · 335
DOI: 10.3390/ph18030335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 26.02.2025. Verfasst von Mohamed A M Abdel Reheim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Arish University, Arish 45511, Egypt. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research and Graduate Studies at King Khalid University, AlMaarefa University, Princess Nourah bint Abdulrahman University.
Abstract (Originalsprache)
Introduction
Inhibiting cyclooxygenase-2 (COX-2) is a potential strategy in inflammation therapy. Thus, developing COX-2 inhibitors plays a pivotal role in efficient inflammation treatment. This study discloses the synthesis of new heterocyclic compounds incorporating pyridine, pyran, and/or pyrazole moieties as COX-2 inhibitors.
Methods
In this study, the Claisen–Schmidt reaction of 1-(5-hydroxy-1,3-diphenyl-1H-pyrazol-4-yl)ethan-1-one 1 and p-methoxybenzaldehyde in ethanol containing aqueous sodium hydroxide (10%) led to the formation of 1-(5-hydroxy-1,3-diphenyl-1H-pyrazol-4-yl)-3-(4-methoxyphenyl)prop-2-en-1-one) 2. The latter compound was allowed to react as a key precursor with various nucleophiles such as ethyl cyanoacetate, malononitrile, cyclohexanone, ethyl acetoacetate, hydrazine, cyano acid hydrazide, hydrazide, and/or thiosemicarbazide to yield new heterocyclic derivatives comprising pyridine, pyran, and/or pyrazole moieties 3–15, according to the Michael addition reaction. The newly synthesized compounds were depicted using spectroscopic techniques such as IR, 1H-NMR, 13C-NMR, and MS. Moreover, their anti-inflammatory efficiency was in vitro evaluated by means of protein denaturation inhibition and cell membrane protection assay.
Results
The results of 2−ΔΔct values of COX-2 expression for compounds 6, 11, 12, and 13 were 6.6, 2.9, 25.8, and 10.1, respectively. Therefore, compound 12, followed by 13, 11, and 6, showed potent anti-inflammatory properties by in vitro evaluation. Further, an in silico molecular docking study was performed on the best-docked compounds and reference drug (Diclofenac) to investigate their binding affinities against the active site of the target enzyme. The obtained results from the in silico study aligned with the biological evaluation.
Conclusions
The studies open new doors for designing new heterocycles containing pyridine, pyran, and/or pyrazole moieties as potent anti-inflammatory agents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Science, Arish University, Arish 45511, Egypt.
- Department of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Giza 12411, Egypt.
- Department of Medicinal Chemistry, Faculty of Pharmacy, South Valley University, Qena 83523, Egypt.
- Department of Biology, College of Science, King Khalid University, P.O. Box 960, Abha 61421, Saudi Arabia.
- Department of Basic Medical Sciences, College of Medicine, AlMaarefa University, P.O. Box 71666, Riyadh 11597, Saudi Arabia.
- Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
ORCID-Profile: Omnia A Mohamed, Abdelfattah Hassan, Fahmy Gad Elsaid, Mamdouh Eldesoqui, Dalal Sulaiman Alshaya, Aboubakr H Abdelmonsef
Förderung
- Deanship of Scientific Research and Graduate Studies at King Khalid University
- AlMaarefa University
- Princess Nourah bint Abdulrahman University
- Deanship of Scientific Research at Northern Border University
- AlMaarefa University, Researchers Supporting Project, AlMaarefa University, Riyadh, Saudi Arabia
- Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
- Deanship of Scientific Research at Northern Border University, Arar, Saudi Arabia
Zitieren
APA
Reheim, M. A. M. A., Rady, H. S. A., Mohamed, O. A., Hassan, A., Hafiz, I. S. A., Reffat, H. M., Elsaid, F. G., Eldesoqui, M., Alshaya, D. S., Badawy, A. A., Fayad, E., & Abdelmonsef, A. H. (2025). Synthesis, Anti-Inflammatory, and Molecular Docking Studies of New Heterocyclic Derivatives Comprising Pyrazole, Pyridine, and/or Pyran Moieties. Pharmaceuticals, 18(3), 335. https://doi.org/10.3390/ph18030335
Vancouver
Reheim MAMA, Rady HSA, Mohamed OA, Hassan A, Hafiz ISA, Reffat HM, et al. Synthesis, Anti-Inflammatory, and Molecular Docking Studies of New Heterocyclic Derivatives Comprising Pyrazole, Pyridine, and/or Pyran Moieties. Pharmaceuticals. 2025;18(3):335. doi:10.3390/ph18030335
BibTeX
@article{Reheim2025,
author = {Reheim, Mohamed A M Abdel and Rady, Hend S Abdel and Mohamed, Omnia A and Hassan, Abdelfattah and Hafiz, Ibrahim S Abdel and Reffat, Hala M and Elsaid, Fahmy Gad and Eldesoqui, Mamdouh and Alshaya, Dalal Sulaiman and Badawy, Abdelnaser A and Fayad, Eman and Abdelmonsef, Aboubakr H},
title = {Synthesis, Anti-Inflammatory, and Molecular Docking Studies of New Heterocyclic Derivatives Comprising Pyrazole, Pyridine, and/or Pyran Moieties},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {3},
pages = {335},
doi = {10.3390/ph18030335}
}
EUVIMED